Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.4 (
deaminase
)
5,113
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The smallest histone deacetylase (HDAC) and the only class IV HDAC member,
HDAC11
, is reported to regulate immune activation and tumorigenesis, yet its biochemical function is largely unknown. Here we identify
HDAC11
as an efficient lysine defatty-
acylase
that is >10,000-fold more efficient than its deacetylase activity. Through proteomics studies, we hypothesized and later biochemically validated SHMT2 as a defatty-acylation substrate of
HDAC11
.
HDAC11
-catalyzed defatty-acylation did not affect the enzymatic activity of SHMT2. Instead, it affects the ability of SHMT2 to regulate type I IFN receptor ubiquitination and cell surface level. Correspondingly,
HDAC11
depletion increased type I IFN signaling in both cell culture and mice. This study not only demonstrates that
HDAC11
has an activity that is much more efficient than the corresponding deacetylase activity, but also expands the physiological functions of
HDAC11
and protein lysine fatty acylation, which opens up opportunities to develop
HDAC11
-specific inhibitors as therapeutics to modulate immune responses.
...
PMID:HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2. 3081 97